Reduced protein synthesis in schizophrenia patient-derived olfactory cells
J A English1, Y Fan2, M Föcking1
1Department of Psychiatry, University College of Dublin School of Biomolecular & Biomedical Science, Royal College of Surgeons in Ireland, Dublin, Ireland.
Abstract:
Human olfactory neurosphere-derived (ONS) cells have the potential to provide novel insights into the cellular pathology of schizophrenia. We used discovery-based proteomics and targeted functional analyses to reveal reductions in 17 ribosomal proteins, with an 18% decrease in the total ribosomal signal intensity in schizophrenia-patient-derived ONS cells. We quantified the rates of global protein synthesis in vitro and found a significant reduction in the rate of protein synthesis in schizophrenia patient-derived ONS cells compared with control-derived cells. Protein synthesis rates in fibroblast cell lines from the same patients did not differ, suggesting cell type-specific effects. Pathway analysis of dysregulated proteomic and transcriptomic data sets from these ONS cells converged to highlight perturbation of the eIF2α, eIF4 and mammalian target of rapamycin (mTOR) translational control pathways, and these pathways were also implicated in an independent induced pluripotent stem cell-derived neural stem model, and cohort, of schizophrenia patients. Analysis in schizophrenia genome-wide association data from the Psychiatric Genetics Consortium specifically implicated eIF2α regulatory kinase EIF2AK2, and confirmed the importance of the eIF2α, eIF4 and mTOR translational control pathways at the level of the genome. Thus, we integrated data from proteomic, transcriptomic, and functional assays from schizophrenia patient-derived ONS cells with genomics data to implicate dysregulated protein synthesis for the first time in schizophrenia.
Insights
Schizophrenia is linked to reduced protein synthesis in brain cells, specifically olfactory neurosphere-derived (ONS) cells. This discovery highlights cell-type specific deficits and implicates key translational control pathways in the disorder.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Schizophrenia pathogenesis remains incompletely understood at the cellular level.
- Olfactory neurosphere-derived (ONS) cells offer a model for studying neuronal pathology in schizophrenia.
- Previous research has not fully elucidated the role of protein synthesis in schizophrenia.
Purpose of the Study:
- To investigate cellular pathology in schizophrenia using human ONS cells.
- To identify molecular mechanisms underlying schizophrenia, focusing on protein synthesis.
- To integrate proteomic, transcriptomic, and genomic data to understand schizophrenia pathophysiology.
Main Methods:
- Discovery-based proteomics and targeted functional analyses on ONS cells from schizophrenia patients and controls.
- Quantification of global protein synthesis rates in vitro.
- Pathway analysis of proteomic and transcriptomic data, integrated with genome-wide association study (GWAS) data.
Main Results:
- Reduced ribosomal protein levels and overall ribosomal signal intensity in schizophrenia patient-derived ONS cells.
- Significantly decreased global protein synthesis rates in ONS cells from schizophrenia patients compared to controls.
- Cell type-specific effects observed, as fibroblast protein synthesis rates did not differ.
- Perturbation of eIF2α, eIF4, and mammalian target of rapamycin (mTOR) translational control pathways identified.
- Genomic analysis implicated EIF2AK2 and confirmed the role of these translational pathways.
Conclusions:
- Dysregulated protein synthesis is implicated in schizophrenia for the first time.
- Cell type-specific deficits in protein synthesis contribute to schizophrenia pathophysiology.
- Translational control pathways (eIF2α, eIF4, mTOR) are critical in schizophrenia, supported by proteomic, transcriptomic, and genomic data.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Olfactory Receptors: Location and Structure


